期刊文献+

经颈静脉肝内门腔静脉分流术后患者并发症的观察及护理 被引量:6

Complications and Nursing Points in Patients after Transjugular Intrahepatic Portosystemic Shunt
下载PDF
导出
摘要 目的探讨经颈静脉肝内门腔静脉分流术(transjugular intrahepatic portosystemic shunt,TIPS)后患者并发症的发生情况及其护理方法。方法回顾性分析2008-2010年在南京大学医学院附属鼓楼医院消化科行TIPS治疗的40例患者出院后6个月内并发症的发生情况,总结其发生原因以及预防和处理这些并发症的经验。结果 TIPS治疗后6个月内的并发症包括腹腔积液、下肢水肿、消化道再出血和肝性脑病等。结论 TIPS术后适当地限制盐和水的摄入、维持正常排便、预防感染、控制蛋白摄入和定期随诊,有助于提高TIPS的长期疗效。 Objective To explore the complications and causes as well as key nursing points in patients after transjugular intrahepatic portosystemic shunt (TIPS). Methods The complications and relevant causes 6 months after TIPS therapy were retrospectively analyzed in 40 patients,and the experience of complicaton prophylaxis and nursing were summarized. Results Ascites,edema of lower extremity,gastrointestinal bleeding and hepatic encephalopathy were the major complications 6 months after TIPS treatment. The main nursing points included proper limitation of salt and water intake, keeping regular and normal defecation, prevention of infection disease, rational protein intake control and regular follow-up in clinic. Conclusion Active follow-up nursing care for patients discharged from hospital after TIPS therapy could probably decrease incidence of complications and benefit long-term effect of TIPS.
作者 张玲 王倩
出处 《解放军护理杂志》 2012年第10期38-40,共3页 Nursing Journal of Chinese People's Liberation Army
基金 南京市卫生局重点课题(ZKX09020)
关键词 经颈静脉肝内门腔静脉分流术 院外 护理 并发症 transjugular intrahepatic portosystemic shunt (TIPS) ,out of hospital,nursing,complication
  • 相关文献

参考文献7

  • 1Arroyo V,Fernandez J. Management of hepatorenal syndrome in patients with cirrhosis[J]. Nat Rev Nephrol, 2011,7(9) :517-526.
  • 2Boyer T D. Transjugular intrahepatic portosystemic shunt (TIPS): Its time has come[J]. J Clin Gastroenterol,2008,42(5) :437-438.
  • 3丁大洪.食管胃底静脉曲张内镜下诊断和治疗规范试行方案[J].中华消化内镜杂志,2000,17(4):198-199. 被引量:395
  • 4Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients.. Meta-analysis update[J]. J Clin Gastroenterol, 2008,42(5):507-516.
  • 5Tzeng W S,Wu R H,Lin C Yet al. Prediction of mortality after emergenttransjugularintrahepatic portosystemic shunt placement: Use of APACHE II, Child-Pugh and MELD scores in asian patients with refractory varicealhemorrhage[J]. Korean J Radiol, 2009,10 (5) : 481-489.
  • 6靳雁,李彩茹,聂燕,袁娟,徐丽,韩晓毅.门脉高压症360例行TIPS术后并发症的护理[J].第四军医大学学报,2009,30(3):246-246. 被引量:2
  • 7Boyer T D, Haskal Z J. American Association for the Study of Liver Diseases Practice Guidelines.. The role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension[J]. J Vase Interv Radiol, 2005,16(5): 615-629.

共引文献395

同被引文献64

  • 1梁和业,高普均,荆雪,韩雪晶,张晗.TIPS临床应用现状[J].吉林医学,2006,27(11):1438-1439. 被引量:7
  • 2Dabos KJ, Haughton BA, Pyleris E, et al. Egional varia- tions in the concentrations of ketone bodies in cirrhosis and hepatic encephalopathy:a study in patients with TIP SS[J]. Liver Int,2011,31(5) :707-711.
  • 3Richter GM,Noeldge G,Palmaz JC,et al. The transjugu- lar intrahepatic portosystemic stent-shunt (TIPSS): re suits of a pilot study[J]. Cardiovasc Intervent Radiol, 1990,13(3) ..200- 207.
  • 4Fidelman N, Kwan SW, LaBerge JM, et al. The transjugu lar intrahepatic portosystemic shunt: an update[J]. A JR Am J Roentgenol,2012,199(4) :746-755.
  • 5Moren OA, Bareen AR, Blazquez J, et al. Partial Splenic Embolization for the Treatment of Hypersplenism in Cir- rhotic HIV/HCV Patients Prior to Pegylated Interferon and Ribavirin[J]. Antivir Ther,2004,9(6) :1027-1030.
  • 6Cohnen M, Ltithen R, D6ubener W, et al. Predictive pa- rameters of infectiologic complications in patients after TIPSS[J]. Radiologe,2003,43(2) : 155-160.
  • 7Engstrom BI, Horvath JJ, Suhocki PV, et al. Covered transjugular intrahepatic portosystemic shunts., accuracy of ultrasound in detecting shunt malfunction [J]. AJR Am J Roentgenol, 2013,200(4) : 904-908.
  • 8lung HS, Kalva SP, Greenfield AJ, et al. TIPS: Compari- son of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stem-grafts [J]. J Vasc Interv Radiol,2009,20(2) :180 185.
  • 9Hausegger KA, Karnel F, Georgieva B, et al. Transj ugular intrahepatic portosystemic shunt creation with the Via torr expanded Polytetrafluoroethylene covered stent-graft [J]. J Vasc Interv Radiol, 2004,15 (3) .. 239-248.
  • 10Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafuoro- ethylene in patientstreated by transjugular intrahepatic portosystemic shunts., longterm results of a randomized multicentre study[J]. Liver Int, 2007,27 (6) : 742-747.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部